Sign in
R&D
Clinical
Commercial
Brand & Marketing
Technology
Insights
Podcast
Awards
LSV Top Industry Leaders Award 2025 Winners
LSV Rising Stars Award 2025 Winner List
More
Manufacturing
Regulatory
Editorial
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
LifeNews
Life Science
Fashion Trends and Culture
R&D
Research & Development
Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development
April 18, 2026
Research & Development
Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies
April 10, 2026
Research & Development
Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research
April 1, 2026
Research & Development
Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D
November 7, 2025
Clinical
Clinical
TIGIT dream fails in phase three, Gilead breaks off its relationship with Arcus
April 25, 2026
Clinical
Merck and Eisai Three-Drug Combination Therapy Fails to Meet Survival Endpoints in Phase 3 RCC Trial
April 25, 2026
Clinical
Actuate Therapeutics medication increases survival chances in pancreatic cancer trial
April 25, 2026
Clinical
Pfizer Stops Work on Next-Gen Drug For Cancer Patients
April 25, 2026
Commercial
All
Brand & Marketing
Commercial
Amneal to Acquire Kashiv BioSciences in Deal Worth Up to $1.1 Billion
April 23, 2026
Commercial
Eli Lilly Acquires CrossBridge Bio in Deal Worth Up to $300 Million
April 23, 2026
Commercial
Lilly to Acquire Kelonia for Up to $7 Billion, Adding Phase 1 In Vivo CAR-T Therapy
April 21, 2026
Technology
Technology
Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI
July 7, 2025
Technology
J&J MedTech presents the first Ottava surgical robot clinical cases
April 17, 2025
Commercial
Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances
October 23, 2024
Technology
PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm
September 26, 2024
Insights
Insights
Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges
April 23, 2026
Insights
How Are Macroeconomic Conditions Impacting Pharma and Biotech Funding?
April 22, 2026
Insights
Top 10 Biotech Podcasts Every Professional Should Listen To in 2026
April 22, 2026
Insights
Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges
April 22, 2026
Podcast
Awards
LSV Top Industry Leaders Award 2025 Winners
LSV Rising Stars Award 2025 Winner List
More
Manufacturing
Regulatory
Editorial
type here...
Search
Facebook
Linkedin
X
Latest news
Clinical
April 25, 2026
TIGIT dream fails in phase three, Gilead breaks off its relationship with Arcus
The domvanalimab, an anti-TIGIT antibody from Gilead Sciences and Arcus Biosciences, is one of the most recent remaining anti-TIGIT...
Clinical
April 25, 2026
Merck and Eisai Three-Drug Combination Therapy Fails to Meet Survival Endpoints in Phase 3 RCC Trial
A late-stage clinical trial evaluating a three-drug combination for renal cell carcinoma (RCC) did not achieve its primary objectives,...
Manufacturing
April 25, 2026
Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1
Replimune is reducing its workforce by 224 employees across its Massachusetts operations following the U.S. Food and Drug Administration’s...
Clinical
April 25, 2026
Actuate Therapeutics medication increases survival chances in pancreatic cancer trial
Results of a mid-stage trial reported that twice as many patients with advanced pancreatic cancer treated with an experimental...
Regulatory
April 25, 2026
FTC, U.S. Anesthesia Partners Reach Settlement in Texas Price Collusion Case
The Federal Trade Commission has reached a settlement with...
Clinical
April 23, 2026
Aligos Therapeutics Secures $25 Million by Granting China Rights for HBV Drug Candidate
Aligos Therapeutics has reached an agreement with hepatology-focused biopharma...
Commercial
April 23, 2026
Amneal to Acquire Kashiv BioSciences in Deal Worth Up to $1.1 Billion
Amneal Pharmaceuticals has agreed to acquire Kashiv BioSciences in a transaction valued at up to $1.1 billion, combining cash...
Commercial
April 23, 2026
Eli Lilly Acquires CrossBridge Bio in Deal Worth Up to $300 Million
Eli Lilly has agreed to acquire CrossBridge Bio, a Houston-based biotechnology company focused on cancer treatments, as part of...
Uncategorized
April 23, 2026
Top 10 Biotech Companies to Watch in 2026
Executive Summary The biotech industry in 2026 is undergoing a structural shift driven by AI-enabled drug discovery, precision medicine, advanced...
Insights
April 23, 2026
Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges
Executive Summary Sustainable practices in pharmaceutical manufacturing in 2026 are...
Insights
April 22, 2026
How Are Macroeconomic Conditions Impacting Pharma and Biotech Funding?
Executive Summary Macroeconomic conditions are significantly reshaping pharma and biotech...
Insights
April 22, 2026
Top 10 Biotech Podcasts Every Professional Should Listen To in 2026
Executive Summary In 2026, staying ahead in biotech is no longer about consuming more content—it’s about learning faster and more...
Insights
April 22, 2026
Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges
Executive Summary Sustainable practices in pharmaceutical manufacturing in 2026 are transitioning from compliance-driven initiatives to core operational strategy. The direct...
Insights
April 22, 2026
Top 10 Life Sciences News Platforms for Industry Insights in 2026
Executive Summary In 2026, staying informed in life sciences is no longer about access to news—it is about access to...
Regulatory
FTC, U.S. Anesthesia Partners Reach Settlement in Texas Price Collusion Case
The Federal Trade Commission has reached a settlement with...
Editorial Team
-
Commercial
Amneal to Acquire Kashiv BioSciences in Deal Worth Up to $1.1 Billion
Amneal Pharmaceuticals has agreed to acquire Kashiv BioSciences in...
Editorial Team
-
Commercial
Allist Secures Leading Role in China’s KRAS Inhibitor Market with $21M Jacobio Deal
Shanghai Allist Pharmaceuticals has significantly bolstered its position in...
Commercial
Novartis spinoff Sandoz to establish HQ in Basel
Novartis' generics spinoff, Sandoz, has announced that it will...
Popular
Most popular life news you must read today
View all articles
Insights
Parkinson’s, autism spectrum disorder, and the gut-brain axis: A role for psychobiotics in ameliorating neurological symptoms from the gut
June 2, 2022
Research & Development
Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028
August 31, 2025
Clinical
Vertex Presses Pause on CF Study, Reports Major Write-Down
May 9, 2025
Commercial
Amneal to Acquire Kashiv BioSciences in Deal Worth Up to $1.1 Billion
Editorial Team
-
April 23, 2026
Eli Lilly Acquires CrossBridge Bio in Deal Worth Up to $300 Million
Editorial Team
-
April 23, 2026
Lilly to Acquire Kelonia for Up to $7 Billion, Adding Phase 1 In Vivo CAR-T Therapy
Editorial Team
-
April 21, 2026
Keebler Raises $16 Million Series A to Advance AI-Based Risk Adjustment Platform
Editorial Team
-
April 18, 2026
BMS and Bain Capital Launch Beeline Medicines with Autoimmune Pipeline Led by Afimetoran
Editorial Team
-
April 18, 2026
Regeneron Partners with Telix in Radiopharmaceutical Collaboration Covering Up to Eight Cancer Programs
Editorial Team
-
April 14, 2026
Information Technology
Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI
Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team
-
July 7, 2025
J&J MedTech presents the first Ottava surgical robot clinical cases
Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team
-
April 17, 2025
Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances
Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team
-
October 23, 2024
PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm
Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team
-
September 26, 2024
Regulatory
Regulatory
FTC, U.S. Anesthesia Partners Reach Settlement in Texas Price Collusion Case
The Federal Trade Commission has reached a settlement with...
Editorial Team
-
Clinical
Merck and Eisai Three-Drug Combination Therapy Fails to Meet Survival Endpoints in Phase 3 RCC Trial
A late-stage clinical trial evaluating a three-drug combination for...
Manufacturing
Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1
Replimune is reducing its workforce by 224 employees across...
Clinical
Actuate Therapeutics medication increases survival chances in pancreatic cancer trial
Results of a mid-stage trial reported that twice as...
Clinical
Pfizer Stops Work on Next-Gen Drug For Cancer Patients
Pfizer has discontinued development of a PD-L1–targeting therapy that...
Research & Development
Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development
April 18, 2026
Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies
April 10, 2026
Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research
April 1, 2026
Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D
November 7, 2025
Market Access
Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1
April 25, 2026
Vivtex Expands R&D and Workforce Following $2.1 Billion Novo Nordisk Partnership
April 13, 2026
UCB to Build $2 Billion Biologics Manufacturing Facility in Georgia
March 31, 2026
Viatris to Cut 10% of Workforce Following Strategic Review and Reports Fire at India Plant
March 1, 2026
Manufacturing
November 24, 2025
FDA Issues Fresh Criticism of Novo Nordisk Indiana Manufacturing Plant
FDA Cites Manufacturing Deficiencies at Indiana Plant Novo Nordisk’s manufacturing...
Manufacturing
November 4, 2025
Lilly’s Plan to Build $3B Dutch Plant Underway, 500 Hires Also in the Pipeline
Eli Lilly Expands European Manufacturing with a $3 Billion...
Manufacturing & Regulatory
POPULAR
Find Your Perfect Music Festival
Clinical
TIGIT dream fails in phase three, Gilead breaks off its relationship with Arcus
The domvanalimab, an anti-TIGIT antibody from Gilead Sciences and...
Editorial Team
-
Manufacturing
Vivtex Expands R&D and Workforce Following $2.1 Billion Novo Nordisk Partnership
Despite securing a partnership valued at up to $2.1...
Editorial Team
-
Manufacturing
Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1
Replimune is reducing its workforce by 224 employees across...
Editorial Team
-